This is not the most recent version of the article. View current version (2 JUN 2016)

Intervention Review

You have free access to this content

Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions

  1. Roger E Thomas1,*,
  2. Tom Jefferson2,
  3. Toby J Lasserson3

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 22 JUL 2013

Assessed as up-to-date: 31 MAR 2013

DOI: 10.1002/14651858.CD005187.pub4


How to Cite

Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD005187. DOI: 10.1002/14651858.CD005187.pub4.

Author Information

  1. 1

    University of Calgary, Department of Family Medicine, Faculty of Medicine, Calgary, Alberta, Canada

  2. 2

    The Cochrane Collaboration, Roma, Italy

  3. 3

    The Cochrane Collaboration, Cochrane Editorial Unit, London, UK

*Roger E Thomas, Department of Family Medicine, Faculty of Medicine, University of Calgary, UCMC, #1707-1632 14th Avenue, Calgary, Alberta, T2M 1N7, Canada. rthomas@ucalgary.ca.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 22 JUL 2013

SEARCH

This is not the most recent version of the article. View current version (02 JUN 2016)

[Figure 1]
Figure 1. Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
[Figure 2]
Figure 2. Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
[Analysis 1.1]
Analysis 1.1. Comparison 1 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 1 Influenza.
[Analysis 1.2]
Analysis 1.2. Comparison 1 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 2 Lower respiratory tract infection.
[Analysis 1.3]
Analysis 1.3. Comparison 1 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 3 Admission to hospital for respiratory illness.
[Analysis 1.4]
Analysis 1.4. Comparison 1 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 4 Deaths from influenza or its complications.
[Analysis 2.1]
Analysis 2.1. Comparison 2 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 1 Influenza.
[Analysis 2.2]
Analysis 2.2. Comparison 2 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 2 Pneumonia.
[Analysis 2.3]
Analysis 2.3. Comparison 2 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 3 Admission to hospital for respiratory illness.
[Analysis 2.4]
Analysis 2.4. Comparison 2 HCWs offered vaccination versus HCWs offered no vaccination: experimental design; data for periods of high influenza activity (Carman and Potter 152; Lemaitre 118 days), Outcome 4 Deaths from influenza or its complications.